Please login to the form below

Not currently logged in
Email:
Password:

Novartis in health technology assessment trial with NICE

Novartis is collaborating with the UK's medicines agency, the National Institute of Health and Clinical Excellence on the joint design of a late-stage clinical trial to assess efficacy and health economics of a new drug

According to the UK newspaper The Financial Times, Swiss-headquartered Novartis has collaborated with the UK's medicines agency, the National Institute of Health and Clinical Excellence (NICE) on the joint design of a late-stage clinical trial.

According to the 17 December article, NICE will charge a fee for informing Novartis which criteria will form the basis of its decision to advise the NHS whether to buy the medicine once it is launched.

In an interview with the FT, Joe Jimenez, Novartis' head of pharmaceuticals, said: "This is about identifying the impact of the drug and the evidence of impact. Input at an early stage gives us the evidence to speed our drug to market. We're looking at more innovative ways to stand behind our drugs."

In November 2007, Novartis consulted with NICE on the design of the phase III trial for the drug, which is currently named Novartis 001.

According to the FT, the results of the trial are expected within a year.

19th December 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics